Cited by 156Neuroscience and Neuropharmacology ResearchTreatment of Major DepressionStress Responses and Cortisol

SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake

Open access
Pinna, Graziano, Costa, Erminio, Guidotti, Alessandro·2009·Current Opinion in Pharmacology

Abstract

Brain principal glutamatergic neurons synthesize 3alpha-hydroxy-5alpha-pregnan-20-one (Allo), a neurosteroid that potently, positively, and allosterically modulates GABA action at GABA(A) receptors. Cerebrospinal fluid (CSF) Allo levels are decreased in patients with posttraumatic stress disorder (PTSD) and major depression. This decrease is corrected by fluoxetine in doses that improve depressive symptoms. Emotional-like behavioral dysfunctions (aggression, fear, and anxiety) associated with a decrease of cortico-limbic Allo content can be induced in mice by social isolation. In socially isolated mice, fluoxetine and analogs stereospecifically normalize the decrease of Allo biosynthesis and improve behavioral dysfunctions by a mechanism independent from 5-HT reuptake inhibition. Thus, fluoxetine and related congeners facilitate GABA(A) receptor neurotransmission and effectively ameliorate emotional and anxiety disorders and depression by acting as selective brain steroidogenic stimulants (SBSSs).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.coph.2008.12.006

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. [1]Diagnostic Statistical Manual of Mental Disorders American Psychiatric Press Washington DC 2000
  2. [2]Berton O Nestler IJ New approaches to antidepressant drug discovery: beyond monoamines Nat Rev Neurosci 2006 7 137 151 16429123
  3. [3]Charney DS Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress Am J Psychiatry 2004 161 195 216 14754765
  4. [4]Wong ML Licinio J From monoamines to genomic targets: a paradigm shift for drug discovery in depression Nat Rev Drug Discov 2004 3 136 151 15040578
  5. [5]Morilak D Frazer A Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders Int J Neuropsychopharmacol 2004 7 193 218 15003145
  6. [6]Kugaya A Sanacora G Verhoeff NP Fujita M Mason GF Seneca NM Bozkurt A Khan SA Anand A Degen K Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT Biol Psychiatry 2003 54 792 799 14550678
  7. [7]Costa E Guidotti A Benzodiazepines on trial: a research strategy for their rehabilitation TIPS 1996 17 192 200 8669126
  8. [9]Puia G Santi MR Vicini S Pritchett DB Purdy RH Paul SM Seeburg PH Costa E Neurosteroids act on recombinant human GABAA receptors Neuron 1990 4 759 765 2160838 ** Demonstrated that 3α, 5α-pregnane neurosteroids potentiate GABA-activated Cl- currents recorded from a human cell line transfected with various human GABAA receptor subunits. These steroids are active at nanomolar concentrations in potentiating GABA-activated Cl- currents.
  9. [10]Puia G Ducic I Vicini S Costa E Does neurosteroid modulatory efficacy depend on GABAA receptor subunit composition? Receptor Channels 1993 1 135 142 8081717
  10. [11]Puia J Mienville JM Matsumoto K Costa E Guidotti A On the putative physiological role of allopregnanolone on GABAA receptor function Neuropharmacology 2003 44 49 55 12559121
  11. [12]Mitchell EA Herd MB Gunn BG Lambert JJ Belelli D Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease Neurochem Int 2008 52 588 595 18055067
  12. [13]Maguire J Mody I GABA(A)R plasticity during pregnancy: relevance to postpartum depression Neuron 2008 59 207 213 18667149 PMC2875248
  13. [14]Cheney DL Uzunov D Costa E Guidotti A Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats J Neurosci 1995 15 4641 4650 7790929 PMC6577709 ** Measured subpicomolar concentrations of allopregnanolone in brain by gas chromatography-mass spectrometry and suggested that the brain is a steroidogenic organ that produces allopregnanolone in physiologically relevant concentrations.
  14. [16]Dong E Matsumoto K Uzunova V Sugaya I Takahata H Watanabe H Costa E Guidotti A Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation Proc Natl Acad Sci USA 2001 98 2849 2854 11226329 PMC30228
  15. [17]Agis-Balboa RC Pinna G Zhubi A Maloku E Veldic M Costa E Guidotti A Characterization of neurons that express enzymes mediating brain neurosteroid biosynthesis Proc Natl Acad Sci USA 2006 103 14602 14607 16984997 PMC1600006 ** Demonstrated that 5α-RI and 3α-HSD colocalize in cortical, hippocampal, olfactory bulb, amygdala, and thalamus glutamatergic principal neurons but not in glial cells or in GABAergic interneurons, suggesting that allopregnanolone acts at GABAA receptors located on dendritic shafts and spines or somata of glutamatergic neurons by reaching GABAA receptor intracellular sites.
  16. [18]Akk G Shu HJ Wang C Steinbach JH Zorumski CF Covery DF Mennerick S Neurosteroid access to the GABAA receptor J Neurosci 2005 25 11605 11613 16354918 PMC6726021
  17. [19]Uzunov DP Cooper TB Costa E Guidotti A Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography Proc Natl Acad Sci USA 1996 93 12599 12604 8901628 PMC38038 ** Fluoxetine dose-dependently increased the content of allopregnanolone in several brain regions of the rat suggesting that a fluoxetine stimulation of brain allopregnanolone biosynthesis might be operative in the anxiolytic and antidysphoric actions of this drug.
  18. [20]Guidotti A Costa E Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 1998 44 865 873 9807641
  19. [21]Uzunova V Sheline Y Davis JM Rasmusson A Uzunov DP Costa E Guidotti A Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine Proc Natl Acad Sci USA 1998 95 3239 3244 9501247 PMC19726 ** CSF allopregnanolone content was lower in patients with major unipolar depression. The normalization of CSF allopregnanolone content in SSRI-treated depressed patients appears to be sufficient to mediate the anxiolytic and antidysphoric actions of SSRIs via its positive allosteric modulation of the action of GABA at GABAA receptors.
  20. [22]Rasmusson AM Pinna G Paliwal P Weisman D Gottschalk C Charney D Krystal J Guidotti A Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder Biol Psychiatry 2006 60 704 713 16934764 * This study suggests that a dysfunction of GABAergic neurotransmission in PTSD may be induced by lower allopregnanolone brain levels.
  21. [23]Rupprecht R Holsboer F Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives Trend Neurosci 1999 9 410 416 10441302
  22. [25]Matsumoto K Uzunova V Pinna G Taki K Uzunov DP Watanabe H Mienville JM Guidotti A Costa E Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss Neuropharmacology 1999 38 955 963 10428414 * Established an association between the decrease of cortical allopregnanolone content and the shortening of pentobarbital sedation. Fluoxetine normalization of these parameters suggests that brain allopregnanolone plays a physiological permissive role in the modulation of GABA-gated Cl- channel function.
  23. [26]Pibiri F Nelson M Guidotti A Costa E Pinna G Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder Proc Natl Acad Sci USA 2008 105 5567 5572 18391192 PMC2291140 * Protracted social isolation of mice combined with contextual fear conditioning exposure may be a suitable model to study the neurochemical correlates of emotion and anxiety spectrum disorders relating to PTSD. Selective activation of neurosteroidogenesis may be a useful intervention in PTSD therapy.
  24. [27]Pinna G Costa E Guidotti A Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses inactive on 5-HT reuptake Psychopharmacology 2006 186 362 372 16432684 * This review provides evidence on new mechanisms of pharmacological action of SSRI and concludes that the term “SSRI” may be misleading in defining the pharmacological profile of fluoxetine and its congeners. The term “selective brain steroidogenic stimulants” (SBSSs) is proposed.
  25. [28]Pinna G Dong E Matsumoto K Costa E Guidotti A In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine Proc Natl Acad Sci USA 2003 100 2035 2040 12571361 PMC149954 * In socially isolated mice, fluoxetine and norfluoxetine stereospecifically reverse brain allopregnanolone downregulation and reduce aggression. The effects of fluoxetine and norfluoxetine on 5-HT reuptake occurs for doses that are 50-fold higher and are not stereospecific.
  26. [29]Agís-Balboa RC Pinna G Pibiri F Kadriu B Costa E Guidotti A Downregulation of neurosteroid biosynthesis in cortico-limbic circuits mediates social isolation induced behavior in mice Proc Natl Acad Sci USA 2007 104 18736 18741 18003893 PMC2141846 * The expression of 5a-RI mRNA is specifically down-regulated in glutamatergic pyramidal neurons that converge on the amygdala from cortical and hippocampal regions and may account for the appearance of behavioral disorders such as anxiety, aggression, and cognitive dysfunction.
  27. [30]Guidotti A Dong E Matsumoto K Pinna G Rasmusson AM Costa E The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders Brain Res Rev 2001 37 110 115 11744079
  28. [31]Serra M Pisu MG Littera M Papi G Sanna E Tuveri F Usala L Purdy RH Biggio GJ Social isolation-induced decreases in both the abundance of neuroactive steroids and GABAA receptor function in rat brain J Neurochem 2000 75 732 740 10899949
  29. [32]Pinna G Pibiri F Agis-Balboa R Nelson M Guidotti A Costa E Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice Neurochemical Research 2008 33 1990 2007 18473173
  30. [33]Pinna G Uzunova V Matsumoto K Puia G Mienville JM Costa E Guidotti A Brain allopregnanolone regulates the potency of the GABAA receptor agonist muscimol Neuropharmacology 2000 39 440 448 10698010 ** Demonstrated for the first time that endogenous allopregnanolone physiologically upregulates GABAergic tone and by such a mechanism plays a permissive/facilitatory role on the muscimol-induced loss of the righting reflex.
  31. [34]Nelson RJ Trainor BC Neural mechanisms of aggression Nat Rev Neurosci 2007 8 536 546 17585306
  32. [35]Milad MR Quirk GJ Pitman RK Orr Sp Fischl B Rauch SL A role for the human dorsal anterior cingulate cortex in fear expression Biol Psychiatry 2007 62 1191 1194 17707349
  33. [37]LeDoux JE Emotion circuits in the brain Annu Rev Neurosci 2000 23 155 158 10845062
  34. [38]Akirav I Maroun M The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear Neural Plast 2007 30873 17502909 PMC1838961
  35. [41]Pinna G Costa E Guidotti A Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids Proc Natl Acad Sci USA 2004 101 6222 6225 15069199 PMC395950 ** Normalization of pentobarbital-induced sedation elicited by the S-isomers of fluoxetine and norfluoxetine is related to the reversal of the downregulation of brain Allo content and is independent of SSRI activity.
  36. [42]Uzunova V Wrynn AS Kinnunen A Ceci M Kohler C Uzunov DP Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat Eur J Pharmacol 2004 486 31 34 14751405
  37. [43]Uzunova V Sampson L Uzunov DP Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action Psychopharmacology 2006 186 351 361 16249906
  38. [44]Griffin LD Mellon SH Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes Proc Natl Acad Sci USA 1999 96 13512 13517 10557352 PMC23979
  39. [45]Sah P Westbrook RF Behavioural neuroscience: The circuit of fear Nature 2008 454 589 590 18668096
  40. [46]Tallarida RJ Murray RB Manual of Pharmacologic Calculations with computer programs Springer New York 2nd 1987

Cited by

Sorted by citations

Authors
Pinna, G., Costa, E., & Guidotti, A.
Affiliations
University of Illinois Chicago (US)
Corresponding author
Pinna, Graziano
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2009-02
Volume
9
Issue
1
Pages
24-30
ISSN
1471-4892 (ISSN-L)
OpenAlex
W2002863546
Cited by
156
References
3
Citations by year
2026: 6 · 2025: 2 · 2024: 9 · 2023: 15 · 2022: 10 · 2021: 9 · 2020: 4 · 2019: 11 · 2018: 13 · 2017: 8 · 2016: 6 · 2015: 11 · 2014: 15 · 2013: 10 · 2012: 5
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health (R01MH056890)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
selective serotonin reuptake inhibitors, fluoxetine, 3alpha-hydroxy-5alpha-pregnan-20-one, neurosteroids, GABA-A receptor modulation, social isolation, post-traumatic stress disorder, major depressive disorder, anxiety disorders
MeSH terms
Animals, Mental Disorders, Brain, Fluoxetine, gamma-Aminobutyric Acid, Humans, Synaptic Transmission, Pregnanolone, Receptors, GABA-A, Social Isolation, Selective Serotonin Reuptake Inhibitors, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review